LUKOSKIN
Roll over image to zoom in
Lukoskin :
Aimil Pharma’s Lukoskin is a polyherbal formulation used for Leucoderma/Vitiligo.
Salient features of Lukoskin
Activates Melanin synthesis- Helps in the release of SH-group bound copper as free copper, which activates tyrosinase activity.
Modulates immunity- Modulates immunity in regard to both non-specific cellular and humoral immune response.
Exerts Photosensitisation- Helps to initiate erythema on the spots of Vitiligo due to its furanocourmarin contents on exposure to UV light or sunlight.
Enhances blister healing- Reduces irritation & the formation of blisters, checks hyperpigmentation in the skin.Directions of use for Cream:
Activates Melanin synthesis- Helps in the release of SH-group bound copper as free copper, which activates tyrosinase activity.
Modulates immunity- Modulates immunity in regard to both non-specific cellular and humoral immune response.
Exerts Photosensitisation- Helps to initiate erythema on the spots of Vitiligo due to its furanocourmarin contents on exposure to UV light or sunlight.
Enhances blister healing- Reduces irritation & the formation of blisters, checks hyperpigmentation in the skin.Directions of use for Cream:
Apply gently on the spots of leucoderma once or twice a day. Apply the ointment from pigmented area to non-pigmented area i.e. from outside to inside. Expose the area after application of the ointment to sun either before 11 a.m. or after 3 p.m. , starting from 6 minutes with an increment period of 2-3 minutes per week till it reaches to 30 minutes of exposure time.Directions of use for Liquid:
Adults – 1 ml. to be taken twice a day after major meals, diluted in 150 ml. – 200 ml. water
Children – 0.5 ml. to be taken twice a day after major meals,
diluted in 150 ml. – 200 ml. water or as directed by the Physician.Use under medical supervision
Children – 0.5 ml. to be taken twice a day after major meals,
diluted in 150 ml. – 200 ml. water or as directed by the Physician.Use under medical supervision
Reviews
There are no reviews yet.